📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
1 articles
AVG GRADE
NEUTRAL
score: 0.00
SENTIMENT
BULLISH
TOTAL VIEWS
2
APLIF Latest News & AI Sentiment Analysis
1 articles · Grade: NEUTRAL · Real-time AI-graded coverage
RECENT COVERAGE · 2 ARTICLES
Appili Therapeutics Announces Receipt from NIAID of a Notice of Termination for Convenience on the Contract for the VXV-01 Program
Appili Therapeutics announced termination of its NIAID-funded contract supporting development of VXV-01, a fungal vaccine candidate....
Appili Therapeutics Reports Fiscal Year 2026 Financial and Operational Results
Appili Therapeutics (APLIF) has disclosed fiscal 2026 results highlighting LIKMEZ® (ATI-1501) commercial traction in the U.S. market....
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice